Provided by Tiger Trade Technology Pte. Ltd.

Atrium Therapeutics

7.93
-0.0600-0.75%
Post-market: 7.930.00000.00%19:58 EDT
Volume:91.82K
Turnover:734.75K
Market Cap:135.65M
PE:-2.06
High:8.13
Open:7.95
Low:7.93
Close:7.99
52wk High:16.77
52wk Low:7.63
Shares:17.11M
Float Shares:15.72M
Volume Ratio:0.25
T/O Rate:0.58%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.8578
EPS(LYR):-3.1905
ROE:-43.98%
ROA:-399.25%
PB:0.63
PE(LYR):-2.49

Loading ...

Atrium Therapeutics - First Participant Expected by End of 2026; Initial Data Anticipated Second Half 2027

THOMSON REUTERS
·
Jul 14

Syngenis banks $4M pre-float to power AI-driven biotech platform

The West Australian
·
Jul 13

Shanghai's Rural Spring Tourism Season Drives 260 Million Yuan in Consumption, Aiming for Sustainable Popularity

Deep News
·
Jul 08

Wave Life Sciences (WVE) Is Up 7.4% After Advancing RNA-Based Obesity Drug Into Phase 2a Trial

Simply Wall St.
·
Jul 05

Does Wave Life Sciences’ (WVE) RNA Obesity Program Signal a Shift in Its Competitive Positioning?

Simply Wall St.
·
Jun 27

ProQR Announces Positive Phase 1 Target Engagement Data for AX-0810, Establishing First Clinical Validation of the Axiomer RNA Editing Platform

GlobeNewswire
·
Jun 25

Does Labcorp’s New RNA At‑Home ColoSense Screening Win Shift The Bull Case For LH?

Simply Wall St.
·
Jun 24

Atrium Therapeutics grants 8 new hires stock awards including 66,000 options at $12.66

Reuters
·
Jun 24

Atrium Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Jun 24

Circio boosts share capital as it advances circular RNA therapy platform

TIPRANKS
·
Jun 22

Genflow’s Chair to Spotlight Longevity and RNA Therapeutics at BIO 2026

TIPRANKS
·
Jun 22

Avidity Biosciences Initiated at Overweight by Cantor Fitzgerald

Dow Jones
·
Jun 18

TransCode Highlights Progress of Lead RNA Cancer Therapeutic

TIPRANKS
·
Jun 18

Atrium Therapeutics initiated with an Overweight at Cantor Fitzgerald

TIPRANKS
·
Jun 18

Circio raises NOK 620 million in 2026 to accelerate circular RNA gene therapy platform

TIPRANKS
·
Jun 10

Sirnaomics Sets EGM to Revamp Equity Incentive Schemes

TIPRANKS
·
Jun 09

Thalia Therapeutics Showcases RNA Strategy in European Biotech Feature

TIPRANKS
·
Jun 09

EXCLUSIVE: TransCode's RNA Therapeutic Achieves 64% Stable Disease Rate In Colorectal Cancer Phase 1 Study

Benzinga_recent_news
·
Jun 03

Thalia Therapeutics Showcases Differentiated RNA Strategy and Cardiovascular Candidate

TIPRANKS
·
Jun 02

Wave Life Sciences to Present at Upcoming Investor Conferences

GlobeNewswire
·
Jun 01